What is Avastin?

Bevacizumab (pronounced /bev-a-Sizz-uh-mab/, trade name Avastin, Genentech/Roche) is an angiogenesis inhibitor, a drug that slows the growth of new blood vessels.

Bevacizumab is a recombinant humanized monoclonal antibody that blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A). VEGF-A is a chemical signal that stimulates angiogenesis in a variety of diseases, especially in cancer. Bevacizumab was the first clinically available angiogenesis inhibitor in the United States.

Bevacizumab was approved by the U.S. Food and Drug Administration (FDA) for certain metastatic cancers. It received its first approval in 2004, for combination use with standard chemotherapy for metastatic colon cancer.

Questions and answers on "Avastin"

Hi, may I answer your health queries right now ? Please type your query here...I had three avastin injections in right eye for macular oedema. The...

doctor1 MD

drug is in trial . follow up for long time ha snot been done so you have to wait see can-be tried the result. drug s food containing anti oxidant...

Read Full Thread   Ask a Doctor Now

Hi. My mum has clear cell ovarian cancer , she was diagnosed two years ago. She had a hysterectomy and went on taxol/ carbo for 6 cycles. NED for...

doctor1 MD

Hi Hinton, it is possible for tumour to spread to bladder and colorectal area and cause bleeding. But it could be related to some infection and...

Read Full Thread   Ask a Doctor Now

My CAT Scan shows I have mild diffuse pancreatic atrophy. I have stage 4 colon cancer and I am being treated with avastin (650 mg/every 3 weeks)...

doctor1 MD

Avastin has no such side effect, even Fluorourasil which may has been combined with avastin as your chemotherapeutic protocols has not such adverde...

Read Full Thread   Ask a Doctor Now

Recent questions on Avastin

Ask Question
Doctor Image

Hi, I am Dr. Andrew Rynne (Family Physician). I will be guiding you through the process. Please write your question below.

Related Drugs/Medications
Related Medical Topics